The study will evaluate the Prodisc C Vivo and Prodisc C SK devices in patients with symptomatic cervical disc disease, according to a news release. Designed to preserve motion and provide stability, total disc replacements prodisc C Vivo and prodisc C SK offer patients an alternative to cervical fusion.
DOCS aims to utilize data from the study to provide patients with the latest technology in future treatment options for musculoskeletal conditions and injuries.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
